Drugs Made In America Acquisition (DMAA) Stock Price, News & Analysis

Company Overview

Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) is a special purpose acquisition company, or SPAC. The company was formed to identify and complete a merger, acquisition, or similar business combination with an operating company.

Its stated focus is on businesses in the pharmaceutical, healthcare, and related life sciences sectors, particularly companies involved in the development, manufacturing, or distribution of products in the United States. Unlike an operating pharmaceutical company, Drugs Made In America Acquisition Corp. does not have its own portfolio of drugs, medical products, or healthcare services.

As a SPAC, the company’s activities have primarily involved raising capital through a public offering, evaluating potential acquisition targets, and pursuing a business combination. Information about a completed transaction, an operating subsidiary, geographic operations beyond its U.S.-focused investment mandate, or a detailed management history is limited.

Key Stats

• Today's Range: $10.89 to $10.89
• 50-Day Range: $10.69 to $10.94
• 52-Week Range: $10.26 to $10.89
• Volume: 925 shs
• Average Volume: 38,241 shs
• Market Capitalization: $265.50 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Company Calendar

• Last Earnings: 8/14/2026
• Today: 10/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Technology
• Industry: Software
• Sub-Industry: Application Software
• Current Symbol: NASDAQ:DMAA
• CIK: 2028614
• Web: dmaacorp.com
• Phone: (954) 870-3104
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 24,280,000
• Free Float: 24,059,000
• Market Cap: $265.50 million
• Optionable: N/A
• Beta: N/A